The downregulation of NPRL2 and its correlation with cisplatin resistance in lung cancer was initially reported almost two decades ago [20, 63], before it was discovered that NPRL2 belongs to the GATOR1 complex [18]. The gene discussed is NPRL2; the disease is lung carcinoma.